Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03934372
Title Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias or Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Incyte Biosciences International Sarl
Indications

Advanced Solid Tumor

lymphoma

acute myeloid leukemia

acute lymphoblastic leukemia

central nervous system cancer

leukemia

chronic myeloid leukemia

Therapies

Ponatinib

Age Groups: child
Covered Countries

Additional content available in CKB BOOST